KCM

Kalehua Capital Management Portfolio holdings

AUM $101M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$101M
AUM Growth
–
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
19
New
Increased
Reduced
Closed

Top Buys

1
+$26.4M
2
+$13.5M
3
+$7.47M
4
RLAY icon
Relay Therapeutics
RLAY
+$6.43M
5
SRZN icon
Surrozen
SRZN
+$6.23M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 73.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BOXX icon
1
Alpha Architect 1-3 Month Box ETF
BOXX
$10B
$26.6M 26.27%
+230,787
XFOR icon
2
X4 Pharmaceuticals
XFOR
$296M
$14.9M 14.73%
+3,722,840
SION
3
Sionna Therapeutics
SION
$1.67B
$8.11M 8.02%
+197,072
RLAY icon
4
Relay Therapeutics
RLAY
$1.59B
$7.63M 7.54%
+901,457
CMPS
5
Compass Pathways
CMPS
$767M
$5.66M 5.59%
+819,692
PHVS icon
6
Pharvaris
PHVS
$1.82B
$5.52M 5.46%
+198,772
SEPN
7
Septerna Inc
SEPN
$1.38B
$5.42M 5.36%
+194,544
ORKA
8
Oruka Therapeutics
ORKA
$1.72B
$3.59M 3.55%
+118,524
IKT icon
9
Inhibikase Therapeutics
IKT
$249M
$3.59M 3.55%
+1,750,000
ALLO icon
10
Allogene Therapeutics
ALLO
$515M
$3.49M 3.45%
+2,546,129
LONA
11
LeonaBio Inc
LONA
$55.5M
$2.98M 2.95%
+393,701
MLTX icon
12
MoonLake Immunotherapeutics
MLTX
$1.29B
$2.32M 2.29%
+175,734
ORIC icon
13
Oric Pharmaceuticals
ORIC
$1.31B
$2.18M 2.16%
+267,059
VRCA icon
14
Verrica Pharmaceuticals
VRCA
$89.4M
$1.96M 1.94%
+235,779
TYRA icon
15
Tyra Biosciences
TYRA
$1.81B
$1.96M 1.94%
+74,465
SRZN icon
16
Surrozen
SRZN
$231M
$1.89M 1.87%
+385,178
TNYA icon
17
Tenaya Therapeutics
TNYA
$132M
$1.42M 1.41%
+2,000,000
KLRS
18
Kalaris Therapeutics
KLRS
$205M
$1.18M 1.17%
+139,901
DMAC icon
19
DiaMedica Therapeutics
DMAC
$445M
$759K 0.75%
+95,359